insights_auto
Zakaj je tečaj EVGN padel 2,43%?
Podrobneje raziščichevron_right
EVGN:NASDAQ
Evogene Ltd
0,42 $
arrow_downward
−2,43%(−0,011) 1D
0,40 $
arrow_downward
−4,71% (−0,020)bedtimePo zaprtju
Zaprto: 2. okt., 16:00:01 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za EVGN …
Odpri
0,41 $
Visoka
0,45 $
Nizka
0,41 $
Tržna kapitalizacija
6,65 mio.
Povprečni promet
2,57 mio.
Promet
146,21 tis.
52-tedenski najvišji tečaj
1,50 $
52-tedenski najnižji tečaj
0,35 $
Čisti dobiček na delnico
−0,91 $
Beta
1,44
Št. izdanih delnic
15,80 mio.
Št. zaposlenih
52
Odpri
0,41 $
Visoka
0,45 $
Nizka
0,41 $
Tržna kapitalizacija
6,65 mio.
Povprečni promet
2,57 mio.
Promet
146,21 tis.
52-tedenski najvišji tečaj
1,50 $
52-tedenski najnižji tečaj
0,35 $
Čisti dobiček na delnico
−0,91 $
Beta
1,44
Št. izdanih delnic
15,80 mio.
Št. zaposlenih
52
Novice
Iz spletnih virov in novičarskih partnerjev
Bloomberg Adria
·
pred 11 urami
Se delnice naenkrat zdijo poceni? To je le optična iluzija (mnenje)
Proactive financial news
·
pred 1 uro
Nova Minerals to host investor webinar on Estelle and US antimony strategy
Simply Wall Street
·
pred 20 minutami
Is New Client Win Altering The Investment Case For ACI Worldwide Stock?
Stock Traders Daily
·
pred 4 urami
Avoiding Lag: Real-Time Signals in (XLSR) Movement
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Vizitka: Evogene Ltd